Author: admin

US President says agreements with more drugmakers will lower costs for patients; critics question what savings consumers will actually see. President Donald Trump on Friday unveiled a fresh set of drug pricing agreements with nine additional pharmaceutical companies, widening the administration’s effort to curb prescription drug costs while temporarily stepping back from threatened import tariffs. With the latest round of commitments, 14 of the 17 drugmakers previously singled out by the White House have now signed on.  The deals follow a common framework: participating companies agree to lower prices for Medicaid recipients, sell select medicines directly to consumers at discounted…

View eBook By creating the first complete map of the human genome, the Human Genome Project made genetics an everyday topic that any well-informed person could comment on. Even so, the human genome is only part of the blueprint of human biology. The real brick-and-mortar building blocks of the body are the constantly changing proteins that make up every structure and are involved in every function. Accurate, large-scale protein measurement has lagged behind DNA sequencing, thanks largely to the immense complexity of the proteome. Unlike the relative simplicity and cellular “sameness” of DNA, proteins come in a vast variety of…

This webinar will be hosted live and available on-demandWednesday, January 21st, 202511:30 AM – 1:00 PM ETSpatial proteomics enables scientists to investigate protein organization at the subcellular, cellular, and tissue levels, including in pathological contexts. Using technologies that help researchers map where proteins are supposed to be in a healthy context and examining how mislocalization disrupts function provides insights across a range of applications, from cancer research to developmental biology.In this webinar brought to you by The Scientist, researchers will discuss the power of spatial proteomics for making health and disease breakthroughs.          Bernd Bodemiller, PhD  Professor  Director, Department…

Boosting mitochondrial supercomplex assembly improves metabolic health and extends lifespan, opening new avenues for therapeutic exploration. Mitochondria have long been celebrated as the powerhouses of the cell, but in aging research they have also emerged as central hubs where metabolic health, reactive oxygen species (ROS) and cellular signaling converge; when their efficiency falters with age, tissues and organs follow suit. In a new study published in Aging Cell, researchers from the Tokyo Metropolitan Institute for Geriatrics and Gerontology and collaborators have investigated whether reinforcing the organizational infrastructure of these organelles can influence aging and longevity. They focused on COX7RP, a…

Created with ChatGPT Biopharma may see a happier year ahead in 2026 than in recent years, according to analysts at William Blair. For one thing, the industry’s top stocks have recovered from lows that stretched into last spring. Blair cited the SPDR S&P Biotech exchange-traded fund (NYSE Arca: XBI), which bounced back from $66.66 a share on April 9, nearly doubling (up 85%) to $123.43 on December 19. Another reason for optimism, the analysts wrote in a recent report, is better-than-expected policies from President Donald Trump’s second administration—from encouraging the reshoring of biopharma manufacturing in the United States to most…

A lipidomics analysis of young Chinese women finds measurable changes in facial skin chemistry as early as the 20s. A new Chinese study suggests that facial skin aging begins at the chemical level earlier than many consumers and brands assume. Researchers analyzing the outermost layer of facial skin in healthy women aged 19 to 33 found clear, age-linked shifts in lipids that help regulate moisture, elasticity, oil balance and appearance. The findings, published in the International Journal of Cosmetic Science, come from a lipidomics study of 151 Chinese women conducted by teams from Shin Biotechnology, the Chinese Academy of Inspection…

Tomatoes are a culinary paradox. To a chef, they are a vegetable; to a botanist, they are a fruit; and to someone suffering from heartburn, they can be a formidable enemy. One of the most common questions surrounding this vibrant nightshade is simple yet scientifically complex: Are tomatoes acidic? The short answer is yes, tomatoes are acidic. However, the nuance lies in how acidic they are, whether that acidity changes when they are cooked or raw, and how that acidity interacts with the human body.  For home canners, the acidity level is a matter of safety. For those with digestive…

Potatoes are everything, from vegans to non-vegetarians; everyone eats potatoes of all kinds. They are the main vegetable in most households. People can not like potatoes, but everyone likes eating French fries made from potatoes. Some people even eat potatoes as the main ingredient of their meals every single day. Are potatoes vegetables? Yes, they are. But, you might be searching on your browser, Are potatoes healthy, Reddit? You might also be asking yourself, Are boiled potatoes healthy? Or, are potatoes healthy for breakfast? Are potatoes healthy carbs? Yes, to all these questions.  And you can get to know a…

Antibiotic resistance is steadily eroding one of modern medicine’s most essential tools. Each year, more than a million people lose their lives to infections that were once easily treatable, a reminder that our current drugs are no longer keeping pace with evolving bacteria. Without new antibiotics, everyday medical procedures—from joint replacements to cancer therapies—carry a growing risk of infections that may no longer respond to treatment. The need for fresh solutions isn’t hypothetical; it’s a practical requirement for maintaining the safety of routine healthcare. To combat drug-resistant infections, researchers from the University of York, led by Angelo Frei, PhD, have…

Combining pharmaceutical sciences and cancer biology, this postdoc studies next-generation drug delivery systems.Image credit:Coptis, ©iStock.com, OlemediaQ | Write a brief introduction to yourself including the lab you work in and your research background. I am Deepika Godugu, and I am currently a postdoctoral researcher in the Department of Pharmaceutical Sciences at St. John’s University. My research focuses on anticancer drug development and evaluation, with expertise in both in vitro cell-based assays and in vivo tumor models. I have a strong background in pharmaceutical sciences, cancer biology, and advanced drug delivery systems, including nanotechnology-based formulations. My technical skills include molecular biology…